Wednesday Aug 25, 2021
11:15 AM - 11:45 AM EDT
Virtual
The emergence and evolution of cell and gene therapy has led many bioanalytical laboratories to implement qPCR and/or ddPCR to support preclinical and clinical assays. While there is a lack of regulatory guidance on how to approach these assays, discussions have already started in the community on harmonizing the approach on the development and validation of qPCR/ddPCR assays. This talk will cover best practices and what should be considered when developing and validating such assays.
Printed courtesy of www.nclifesci.org/ – Contact the NC Life Sciences Organization for more information.
4505 Emperor Blvd, Ste 105, Durham, NC 27703 – (919) 281-8960 – Admin@NCLifeSci.org